NewsBenzingaTruist Securities mantiene la recomendación de compra sobre Hinge Health y eleva el precio objetivo a 145 dólares Truist Securities mantiene la recomendación de compra sobre Hinge Health y eleva el precio objetivo a 145 dólares Benzinga 2026.11.03 16:53 (GMT+0) Open on Benzinga Other news T1 Energy Stock Plunges: What's Going On? Why Nvidia Is Falling Tuesday: Jensen Huang’s Comeback Statement, Congress Hearings, and AI Risks General Motors Plans 20% Boost In Robotics As Factory Costs Rise Eli Lilly Inks Multibillion-Dollar Pact to Develop Precision Cancer Therapies 'Nvidia stopped disclosing Singapore sales as revenues hit $104B' -FT Nike CEO Says Co Aims To Double The Units Of Product Created In Under 14 Months By FY31